Lung Disease-Related Pulmonary Hypertension.
Publication/Presentation Date
2-1-2022
Abstract
Patients with advanced lung disease can develop pulmonary hypertension and succumb to right ventricular failure/cor pulmonale. Patients with pulmonary hypertension owing to chronic lung disease, or World Health Organization group 3 pulmonary hypertension, are more limited and carry a high risk of mortality. Adjunctive therapies remain the cornerstones of treatment. Recent evidence suggests that inhaled pulmonary vasodilator therapy can be helpful in patients with pulmonary hypertension owing to interstitial lung disease. Lung transplantation may be the only life-saving option in select patients, whereas palliative care and hospice should be sought for those who are not candidates as the disease progresses.
Volume
40
Issue
1
First Page
77
Last Page
88
ISSN
1558-2264
Published In/Presented At
Ahmad, K., Khangoora, V., & Nathan, S. D. (2022). Lung Disease-Related Pulmonary Hypertension. Cardiology clinics, 40(1), 77–88. https://doi.org/10.1016/j.ccl.2021.08.005
Disciplines
Medicine and Health Sciences
PubMedID
34809919
Department(s)
Department of Medicine
Document Type
Article